Crosstalk Between H-Type Vascular Endothelial Cells and Macrophages: A Potential Regulator of Bone Homeostasis
Jiaxuan Fan,
No information about this author
Yaohui Xie,
No information about this author
Dayin Liu
No information about this author
et al.
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 2743 - 2765
Published: Feb. 1, 2025
The
crosstalk
between
H-type
endothelial
cells
(ECs)
and
macrophages
is
critical
for
maintaining
angiogenesis
osteogenesis
in
bone
homeostasis.
As
core
components
of
type
H
vessels,
ECs
respond
to
various
pro-angiogenic
signals,
forming
specialized
vascular
structures
characterized
by
high
expression
platelet-endothelial
cell
adhesion
molecule-1
(CD31)
mucin
(EMCN),
thereby
facilitating
angiogenesis-osteogenesis
coupling
during
formation.
Macrophages,
as
key
immune
the
perivascular
region,
are
primarily
classified
into
classically
activated
pro-inflammatory
M1
phenotype
selectively
anti-inflammatory
M2
phenotype,
performing
dual
functions
regulating
local
tissue
homeostasis
innate
immunity.
In
recent
years,
complex
vessel
has
garnered
significant
interest
context
bone-related
diseases.
Orderly
regulation
immunity
provides
a
new
direction
preventing
metabolic
disorders
such
osteoporosis
osteoarthritis.
However,
their
interactions
remain
insufficiently
understood,
with
limited
clinical
data
available.
This
review
comprehensively
examines
intricate
diverse
phenotypes,
Insights
signaling
pathways
that
regulate
crosstalk,
focusing
on
roles
osteogenesis.
Furthermore,
discusses
interventions
targeting
this
challenges
remain.
These
insights
may
offer
perspectives
provide
theoretical
foundation
developing
novel
therapeutic
strategies.
Language: Английский
Differential risk of autoimmune disorders in Non-Traumatic Osteonecrosis: clue to pathogenesis
Expert Review of Clinical Immunology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 4, 2025
Non-traumatic
osteonecrosis
is
a
frequent
complication
in
patients
with
autoimmune
disorders,
though
its
prevalence
varies
markedly
depending
upon
the
type
of
disorder.
Understanding
causes
this
difference
can
help
uncover
underlying
pathophysiology
and
guide
development
effective
preventive
therapeutic
strategies.
In
perspective
study,
we
reviewed
available
databases,
including
PubMed,
Cochrane
Library,
Scopus,
Web
Science,
to
explore
why
risk
among
different
disorders.
Is
variation
primarily
due
disease's
pathophysiology,
use
medications
such
as
corticosteroids,
or
combination
both?
If
both
factors
are
involved,
what
extent
each
contribution
context?
often
induced
by
an
interaction
between
disease
corticosteroid
use.
disorders
but
identical
history
use,
influenced
how
compromises
bone
health.
multiple
adverse
effects
on
bone,
SLE
(systemic
lupus
erythematosus),
there
much
higher
compared
minimal
impact
health,
celiac
MS
(multiple
sclerosis).
Language: Английский
Microstructural and transcriptomic characterization of trabecular bone in idiopathic osteonecrosis of the femoral head
Laura Saldaña,
No information about this author
Gema Vallés,
No information about this author
Nuria Vilaboa
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: April 8, 2025
Language: Английский
Exploring the feasibility of pharmacologic management in non-traumatic osteonecrosis: An etiology-based hypothesis
Medical Hypotheses,
Journal Year:
2024,
Volume and Issue:
193, P. 111497 - 111497
Published: Oct. 9, 2024
Language: Английский
Potential molecular targets for the pharmacologic management of non-traumatic osteonecrosis
Expert Opinion on Therapeutic Targets,
Journal Year:
2024,
Volume and Issue:
28(11), P. 991 - 1000
Published: Oct. 29, 2024
Non-traumatic
osteonecrosis
is
a
debilitating
condition
marked
by
bone
death,
primarily
due
to
reduced
blood
supply.
Currently,
no
effective
pharmacologic
intervention
available
manage
this
effectively.
Language: Английский
Identification of shared gene signatures for diagnosing Systemic lupus erythematosus with osteonecrosis of the femoral head through bioinformatics analysis and machine learning
Fei-Long Lu,
No information about this author
Wenbin Zhang,
No information about this author
Yulin Ma
No information about this author
et al.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 24, 2024
Abstract
Background:
Osteonecrosis
of
the
femoral
head
(ONFH)
is
a
severe
complication
systemic
lupus
erythematosus
(SLE).
Although
there
characteristic
disease
spectrum
between
SLE
and
ONFH,
exact
pathogenesis
remains
unclear.
Furthermore,
lack
early
diagnostic
criteria
complicates
diagnosis
SLE-ONFH.
This
study
aimed
to
identify
key
candidate
genes
in
patients
with
ONFH.
Methods:
ONFH
datasets
were
obtained
from
Gene
Expression
Omnibus
(GEO).
Differentially
expressed
(DEGs)
module
identified
using
Limma
Weighted
Co-expression
Network
Analysis
(WGCNA),
followed
by
Ontology
(GO)
Kyoto
Encyclopedia
Genes
Genomes
(KEGG)
enrichment
analyses.
A
protein‒protein
interaction
(PPI)
network
was
constructed,
machine
learning
algorithms—extreme
gradient
boosting
(XGB),
support
vector
(SVM),
random
forest
(RF),
generalized
linear
models
(GLMs)—were
applied
hub
for
diagnosing
combined
Receiver
operating
(ROC)
curves
nomograms
generated.
Results:
The
dataset
included
493
DEGs
1,171
genes.
384
525
By
intersecting
genes,
total
74
obtained,
which
mainly
enriched
"chemokine
signaling
pathway"
"cytokine‒cytokine
receptor
pathway."
constructing
PPI
network,
22
node
identified.
Using
learning,
five
highest
scores
selected
nomogram
construction
value
evaluation.
all
demonstrated
high
value.
Conclusion:
results
this
indicate
that
ELANE,
LTF,
ALAS2,
MX1,
CA1
are
provides
new
direction
clinical
prediction
Language: Английский
Insights into Medication-Induced Osteonecrosis of the Jaw Through the Application of Salivary Proteomics and Bioinformatics
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(22), P. 12405 - 12405
Published: Nov. 19, 2024
Long-term
treatment
with
bisphosphonates
is
accompanied
by
an
increased
risk
of
medication-related
osteonecrosis
the
jaw
(MRONJ).
Currently,
no
clinically
useful
biomarkers
for
predictive
diagnosis
MRONJ
are
available.
To
investigate
potential
key
proteins
involved
in
pathogenesis
MRONJ,
a
proteomic
LC-MS/MS
analysis
saliva
was
performed.
Differentially
expressed
(DEPs)
were
analyzed
using
BiNGO,
ClueGO,
cytoHubba,
MCODE,
KEGG,
and
ReactomeFI
software
packages
Cytoscape
platforms.
In
total,
1545
DEPs
identified,
including
43
up-
11
down-regulated
1.5-fold
cut-off
value
Language: Английский